Global (United States, European Union and China) Treatment and Prevention of Herpes Labialis Market Research Report 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 120

Report ID: 300370

In 2019, the market size of Treatment and Prevention of Herpes Labialis is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Treatment and Prevention of Herpes Labialis.

This report studies the global market size of Treatment and Prevention of Herpes Labialis, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Treatment and Prevention of Herpes Labialis sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
GSK
Novartis
Teva
Mylan
Cadila
Apotex
Daewoong Pharmaceutical
Livzon
Luoxin
Med shine
Bayer (Campho Phenique)
Blistex
Kelun Group
Hikma
Haiwang
Carmex
Cipher

Market Segment by Product Type
Valacyclovir
Aciclovir
Famciclovir
Docosanol
Other

Market Segment by Application
External Use
Oral
Injection

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Treatment and Prevention of Herpes Labialis status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Treatment and Prevention of Herpes Labialis manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Treatment and Prevention of Herpes Labialis are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Treatment and Prevention of Herpes Labialis Market Size Growth Rate by Type (2019-2025)
1.3.2 Valacyclovir
1.3.3 Aciclovir
1.3.4 Famciclovir
1.3.5 Docosanol
1.3.6 Other
1.4 Market Segment by Application
1.4.1 Global Treatment and Prevention of Herpes Labialis Market Share by Application (2019-2025)
1.4.2 External Use
1.4.3 Oral
1.4.4 Injection
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Treatment and Prevention of Herpes Labialis Market Size
2.1.1 Global Treatment and Prevention of Herpes Labialis Revenue 2014-2025
2.1.2 Global Treatment and Prevention of Herpes Labialis Sales 2014-2025
2.2 Treatment and Prevention of Herpes Labialis Growth Rate by Regions
2.2.1 Global Treatment and Prevention of Herpes Labialis Sales by Regions 2014-2019
2.2.2 Global Treatment and Prevention of Herpes Labialis Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 Treatment and Prevention of Herpes Labialis Sales by Manufacturers
3.1.1 Treatment and Prevention of Herpes Labialis Sales by Manufacturers 2014-2019
3.1.2 Treatment and Prevention of Herpes Labialis Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Treatment and Prevention of Herpes Labialis Revenue by Manufacturers (2014-2019)
3.2.2 Treatment and Prevention of Herpes Labialis Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Treatment and Prevention of Herpes Labialis Market Concentration Ratio (CR5 and HHI)
3.3 Treatment and Prevention of Herpes Labialis Price by Manufacturers
3.4 Key Manufacturers Treatment and Prevention of Herpes Labialis Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Treatment and Prevention of Herpes Labialis Market
3.6 Key Manufacturers Treatment and Prevention of Herpes Labialis Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Valacyclovir Sales and Revenue (2014-2019)
4.1.2 Aciclovir Sales and Revenue (2014-2019)
4.1.3 Famciclovir Sales and Revenue (2014-2019)
4.1.4 Docosanol Sales and Revenue (2014-2019)
4.1.5 Other Sales and Revenue (2014-2019)
4.2 Global Treatment and Prevention of Herpes Labialis Sales Market Share by Type
4.3 Global Treatment and Prevention of Herpes Labialis Revenue Market Share by Type
4.4 Treatment and Prevention of Herpes Labialis Price by Type

5 Market Size by Application
5.1 Overview
5.2 Global Treatment and Prevention of Herpes Labialis Sales by Application

6 United States
6.1 United States Treatment and Prevention of Herpes Labialis Breakdown Data by Company
6.2 United States Treatment and Prevention of Herpes Labialis Breakdown Data by Type
6.3 United States Treatment and Prevention of Herpes Labialis Breakdown Data by Application

7 European Union
7.1 European Union Treatment and Prevention of Herpes Labialis Breakdown Data by Company
7.2 European Union Treatment and Prevention of Herpes Labialis Breakdown Data by Type
7.3 European Union Treatment and Prevention of Herpes Labialis Breakdown Data by Application

8 China
8.1 China Treatment and Prevention of Herpes Labialis Breakdown Data by Company
8.2 China Treatment and Prevention of Herpes Labialis Breakdown Data by Type
8.3 China Treatment and Prevention of Herpes Labialis Breakdown Data by Application

9 Rest of World
9.1 Rest of World Treatment and Prevention of Herpes Labialis Breakdown Data by Company
9.2 Rest of World Treatment and Prevention of Herpes Labialis Breakdown Data by Type
9.3 Rest of World Treatment and Prevention of Herpes Labialis Breakdown Data by Application
9.4 Rest of World Treatment and Prevention of Herpes Labialis Breakdown Data by Countries
9.4.1 Rest of World Treatment and Prevention of Herpes Labialis Sales by Countries
9.4.2 Rest of World Treatment and Prevention of Herpes Labialis Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia

10 Company Profiles
10.1 GSK
10.1.1 GSK Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Treatment and Prevention of Herpes Labialis
10.1.4 Treatment and Prevention of Herpes Labialis Product Introduction
10.1.5 GSK Recent Development
10.2 Novartis
10.2.1 Novartis Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Treatment and Prevention of Herpes Labialis
10.2.4 Treatment and Prevention of Herpes Labialis Product Introduction
10.2.5 Novartis Recent Development
10.3 Teva
10.3.1 Teva Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Treatment and Prevention of Herpes Labialis
10.3.4 Treatment and Prevention of Herpes Labialis Product Introduction
10.3.5 Teva Recent Development
10.4 Mylan
10.4.1 Mylan Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Treatment and Prevention of Herpes Labialis
10.4.4 Treatment and Prevention of Herpes Labialis Product Introduction
10.4.5 Mylan Recent Development
10.5 Cadila
10.5.1 Cadila Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Treatment and Prevention of Herpes Labialis
10.5.4 Treatment and Prevention of Herpes Labialis Product Introduction
10.5.5 Cadila Recent Development
10.6 Apotex
10.6.1 Apotex Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Treatment and Prevention of Herpes Labialis
10.6.4 Treatment and Prevention of Herpes Labialis Product Introduction
10.6.5 Apotex Recent Development
10.7 Daewoong Pharmaceutical
10.7.1 Daewoong Pharmaceutical Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Treatment and Prevention of Herpes Labialis
10.7.4 Treatment and Prevention of Herpes Labialis Product Introduction
10.7.5 Daewoong Pharmaceutical Recent Development
10.8 Livzon
10.8.1 Livzon Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Treatment and Prevention of Herpes Labialis
10.8.4 Treatment and Prevention of Herpes Labialis Product Introduction
10.8.5 Livzon Recent Development
10.9 Luoxin
10.9.1 Luoxin Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Treatment and Prevention of Herpes Labialis
10.9.4 Treatment and Prevention of Herpes Labialis Product Introduction
10.9.5 Luoxin Recent Development
10.10 Med shine
10.10.1 Med shine Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Treatment and Prevention of Herpes Labialis
10.10.4 Treatment and Prevention of Herpes Labialis Product Introduction
10.10.5 Med shine Recent Development
10.11 Bayer (Campho Phenique)
10.12 Blistex
10.13 Kelun Group
10.14 Hikma
10.15 Haiwang
10.16 Carmex
10.17 Cipher

11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Treatment and Prevention of Herpes Labialis Sales Channels
11.2.2 Treatment and Prevention of Herpes Labialis Distributors
11.3 Treatment and Prevention of Herpes Labialis Customers

12 Market Forecast
12.1 Global Treatment and Prevention of Herpes Labialis Sales and Revenue Forecast 2019-2025
12.2 Global Treatment and Prevention of Herpes Labialis Sales Forecast by Type
12.3 Global Treatment and Prevention of Herpes Labialis Sales Forecast by Application
12.4 Treatment and Prevention of Herpes Labialis Forecast by Regions
12.4.1 Global Treatment and Prevention of Herpes Labialis Sales Forecast by Regions 2019-2025
12.4.2 Global Treatment and Prevention of Herpes Labialis Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India

13 Research Findings and Conclusion

14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer